Article
Measurement of mutation frequency at the HPRT locus in peripheral lymphocytes. Is this a good method to evaluate a cancer risk in pediatric patients?
Advances in experimental medicine and biology - 1 Jan 1998
Lin Y W, Kubota M, Akiyama Y, Sawada M, Furusho K
Abstract excerpt
Validity of measurement of somatic cell mutation frequency (Mf) at the hprt locus for evaluating cancer risk of the given individual was determined in pediatric patients. Peripheral lymphocytes (PL) from patients with various diseases, including acute lymphoblastic leukemia (ALL) and Hodgkin's disease (HD), DNA repair deficient syndromes or short stature receiving growth hormone (GH), were isolated through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
